Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)

Abstract. Bacterial vaginosis (BV) is an infection that has a prevalence between 10% to 50% worlwide. BV results in an imbalance of the normal vaginal flora. Microorganisms associated with BV have been isolated from the normal flora of the male genital tract, and their presence could be related to t...

Full description

Autores:
Viveros Carreño, David Andrés
Sierra Barrios, Eloisa Mercedes
Tipo de recurso:
Trabajo de grado de pregrado
Fecha de publicación:
2016
Institución:
Universidad Nacional de Colombia
Repositorio:
Universidad Nacional de Colombia
Idioma:
spa
OAI Identifier:
oai:repositorio.unal.edu.co:unal/58852
Acceso en línea:
https://repositorio.unal.edu.co/handle/unal/58852
http://bdigital.unal.edu.co/55847/
Palabra clave:
61 Ciencias médicas; Medicina / Medicine and health
Sexual partners
Bacterial vaginosis
Treatment
Compañeros sexuales
Vaginosis bacteriana
Tratamiento
Rights
openAccess
License
Atribución-NoComercial 4.0 Internacional
id UNACIONAL2_9dc4646792ca46ade5190f2642c3c0ac
oai_identifier_str oai:repositorio.unal.edu.co:unal/58852
network_acronym_str UNACIONAL2
network_name_str Universidad Nacional de Colombia
repository_id_str
dc.title.spa.fl_str_mv Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)
title Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)
spellingShingle Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)
61 Ciencias médicas; Medicina / Medicine and health
Sexual partners
Bacterial vaginosis
Treatment
Compañeros sexuales
Vaginosis bacteriana
Tratamiento
title_short Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)
title_full Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)
title_fullStr Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)
title_full_unstemmed Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)
title_sort Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)
dc.creator.fl_str_mv Viveros Carreño, David Andrés
Sierra Barrios, Eloisa Mercedes
dc.contributor.author.spa.fl_str_mv Viveros Carreño, David Andrés
Sierra Barrios, Eloisa Mercedes
dc.contributor.spa.fl_str_mv Amaya Guio, Jairo
Grillo Ardila, Carlos Fernando
dc.subject.ddc.spa.fl_str_mv 61 Ciencias médicas; Medicina / Medicine and health
topic 61 Ciencias médicas; Medicina / Medicine and health
Sexual partners
Bacterial vaginosis
Treatment
Compañeros sexuales
Vaginosis bacteriana
Tratamiento
dc.subject.proposal.spa.fl_str_mv Sexual partners
Bacterial vaginosis
Treatment
Compañeros sexuales
Vaginosis bacteriana
Tratamiento
description Abstract. Bacterial vaginosis (BV) is an infection that has a prevalence between 10% to 50% worlwide. BV results in an imbalance of the normal vaginal flora. Microorganisms associated with BV have been isolated from the normal flora of the male genital tract, and their presence could be related to the recurrence of BV after antibiotic treatment. Therefore, the treatment of sexual partners could decrease the recurrence of infection and possibly the burden of the disease. The objective of the revision was to assess the effectiveness in women and the safety in men of concurrent antibiotic treatment for the sexual partners of women treated for BV. Seven RCTs (1026 participants) met our inclusion criteria, and pharmaceutical industry funded four of these trials. Based on high quality evidence, antibiotic treatment does not increase the rate of clinical or symptomatic improvement in women during the first week (risk ratio (RR) 0.99, 95% confidence interval (CI) 0.96 to 1.03; RR 1.06, 95% CI 1.00 to 1.12, respectively), between the first and fourth week (RR 1.02, 95% CI 0.94 to 1.11; RR 0.93, 95% CI 0.84 to 1.03, respectively) or after the fourth week (RR 0.98, 95% CI 0.90 to 1.07; RR 1.03, 95% CI 0.90 to 1.17, respectively). With low quality evidence antibiotic treatment does not led to a lower recurrence during the first and fourth week (RR 1.28, 95% CI 0.68 to 2.43) or after the fourth week of treatment (RR 1.00, 95% CI 0.67 to 1.52) in women, but increases the frequency of adverse events reported by sexual partners (RR 2.55, 95% CI 1.55 to 4.18).
publishDate 2016
dc.date.issued.spa.fl_str_mv 2016-10-01
dc.date.accessioned.spa.fl_str_mv 2019-07-02T14:54:59Z
dc.date.available.spa.fl_str_mv 2019-07-02T14:54:59Z
dc.type.spa.fl_str_mv Trabajo de grado - Pregrado
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/bachelorThesis
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/acceptedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_7a1f
dc.type.content.spa.fl_str_mv Text
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/TP
format http://purl.org/coar/resource_type/c_7a1f
status_str acceptedVersion
dc.identifier.uri.none.fl_str_mv https://repositorio.unal.edu.co/handle/unal/58852
dc.identifier.eprints.spa.fl_str_mv http://bdigital.unal.edu.co/55847/
url https://repositorio.unal.edu.co/handle/unal/58852
http://bdigital.unal.edu.co/55847/
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.spa.fl_str_mv http://www.cochrane.org/CD011701/STI_antibiotic-treatment-sexual-partners-women-bacterial-vaginosis
dc.relation.ispartof.spa.fl_str_mv Universidad Nacional de Colombia Sede Bogotá Facultad de Medicina Departamento de Obstetricia y Ginecología
Departamento de Obstetricia y Ginecología
dc.relation.references.spa.fl_str_mv Viveros Carreño, David Andrés and Sierra Barrios, Eloisa Mercedes (2016) Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol). Otra thesis, Universidad Nacional de Colombia - Sede Bogotá.
dc.rights.spa.fl_str_mv Derechos reservados - Universidad Nacional de Colombia
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.license.spa.fl_str_mv Atribución-NoComercial 4.0 Internacional
dc.rights.uri.spa.fl_str_mv http://creativecommons.org/licenses/by-nc/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv Atribución-NoComercial 4.0 Internacional
Derechos reservados - Universidad Nacional de Colombia
http://creativecommons.org/licenses/by-nc/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
institution Universidad Nacional de Colombia
bitstream.url.fl_str_mv https://repositorio.unal.edu.co/bitstream/unal/58852/1/1032453866_1065578098.2016.pdf
https://repositorio.unal.edu.co/bitstream/unal/58852/2/1032453866_1065578098.2016.pdf.jpg
bitstream.checksum.fl_str_mv 17ff87941dad07e5547bb36f8d5609de
e36a64da8834113c03ca3c57bbea15c3
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad Nacional de Colombia
repository.mail.fl_str_mv repositorio_nal@unal.edu.co
_version_ 1806885936961683456
spelling Atribución-NoComercial 4.0 InternacionalDerechos reservados - Universidad Nacional de Colombiahttp://creativecommons.org/licenses/by-nc/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Amaya Guio, JairoGrillo Ardila, Carlos FernandoViveros Carreño, David Andrésc21e0e1f-59d3-4555-a9d7-30712bff7e80300Sierra Barrios, Eloisa Mercedesb587b1b4-53e8-4e0e-8b02-3aba5dff30b13002019-07-02T14:54:59Z2019-07-02T14:54:59Z2016-10-01https://repositorio.unal.edu.co/handle/unal/58852http://bdigital.unal.edu.co/55847/Abstract. Bacterial vaginosis (BV) is an infection that has a prevalence between 10% to 50% worlwide. BV results in an imbalance of the normal vaginal flora. Microorganisms associated with BV have been isolated from the normal flora of the male genital tract, and their presence could be related to the recurrence of BV after antibiotic treatment. Therefore, the treatment of sexual partners could decrease the recurrence of infection and possibly the burden of the disease. The objective of the revision was to assess the effectiveness in women and the safety in men of concurrent antibiotic treatment for the sexual partners of women treated for BV. Seven RCTs (1026 participants) met our inclusion criteria, and pharmaceutical industry funded four of these trials. Based on high quality evidence, antibiotic treatment does not increase the rate of clinical or symptomatic improvement in women during the first week (risk ratio (RR) 0.99, 95% confidence interval (CI) 0.96 to 1.03; RR 1.06, 95% CI 1.00 to 1.12, respectively), between the first and fourth week (RR 1.02, 95% CI 0.94 to 1.11; RR 0.93, 95% CI 0.84 to 1.03, respectively) or after the fourth week (RR 0.98, 95% CI 0.90 to 1.07; RR 1.03, 95% CI 0.90 to 1.17, respectively). With low quality evidence antibiotic treatment does not led to a lower recurrence during the first and fourth week (RR 1.28, 95% CI 0.68 to 2.43) or after the fourth week of treatment (RR 1.00, 95% CI 0.67 to 1.52) in women, but increases the frequency of adverse events reported by sexual partners (RR 2.55, 95% CI 1.55 to 4.18).Resumen. La vaginosis bacteriana es una infección muy frecuente, con una prevalencia que varía entre el 10% y el 50%. Los microorganismos asociados con la VB han sido aislados de la flora normal del tracto masculino y su presencia podría estar relacionada con la recurrencia de la infección luego del tratamiento. De esta manera, el tratamiento a la pareja sexual podría ofrecer las ventajas de disminuir la recurrencia de la infección, romper la cadena de infección y posiblemente disminuir la carga de la enfermedad. El objetivo de la revisión fue Determinar la efectividad y seguridad del tratamiento antibiótico concurrente a la pareja sexual de mujeres tratadas para VB. Siete Ensayos clínicos controlados (1026 participantes) cumplieron los criterios de inclusión, cuatro de ellos fueron patrocinados por la industria. Encontramos con evidencia de alta calidad que el tratamiento antibiótico no incrementa la tase de mejora clínica o sintomática durante la primera semana (RR 0.9, IC 95% 0.96 a 1.03; RR 1.06, IC 95% 1.00 a 1.12 respectivamente), entre la primer y cuarta semana (RR 1.02, IC 95% 0.94 a 1.11; RR 0.93, IC 95% 0.84 a 1.03 respectivamente) o después de la cuarta semana (RR 0.98, IC 95% 0.90 a 1.07; RR 1.03 con IC 95% 0.90 a 1.17 respectivamente). Con calidad de evidencia baja el tratamiento antibiótico no llevó a una menor tasa de recurrencia durante la primer y cuarta semana (RR 1.28, IC 95% 0.68 a 2.43) o después de la cuarta semana de tratamiento (RR 1.00, IC 95% 0.67 a 1.52) pero incrementó la frecuencia de eventos adversos reportados por los compañeros sexuales (RR 2.55, IC 1.55 a 4.18).Otraapplication/pdfspahttp://www.cochrane.org/CD011701/STI_antibiotic-treatment-sexual-partners-women-bacterial-vaginosisUniversidad Nacional de Colombia Sede Bogotá Facultad de Medicina Departamento de Obstetricia y GinecologíaDepartamento de Obstetricia y GinecologíaViveros Carreño, David Andrés and Sierra Barrios, Eloisa Mercedes (2016) Antibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol). Otra thesis, Universidad Nacional de Colombia - Sede Bogotá.61 Ciencias médicas; Medicina / Medicine and healthSexual partnersBacterial vaginosisTreatmentCompañeros sexualesVaginosis bacterianaTratamientoAntibiotic treatment for the sexual partner of women with Bacterial Vaginosis (Protocol)Trabajo de grado - Pregradoinfo:eu-repo/semantics/bachelorThesisinfo:eu-repo/semantics/acceptedVersionhttp://purl.org/coar/resource_type/c_7a1fTexthttp://purl.org/redcol/resource_type/TPORIGINAL1032453866_1065578098.2016.pdfapplication/pdf1852999https://repositorio.unal.edu.co/bitstream/unal/58852/1/1032453866_1065578098.2016.pdf17ff87941dad07e5547bb36f8d5609deMD51THUMBNAIL1032453866_1065578098.2016.pdf.jpg1032453866_1065578098.2016.pdf.jpgGenerated Thumbnailimage/jpeg5098https://repositorio.unal.edu.co/bitstream/unal/58852/2/1032453866_1065578098.2016.pdf.jpge36a64da8834113c03ca3c57bbea15c3MD52unal/58852oai:repositorio.unal.edu.co:unal/588522023-03-29 23:09:31.719Repositorio Institucional Universidad Nacional de Colombiarepositorio_nal@unal.edu.co